Armata Pharmaceuticals Inc logo

Armata Pharmaceuticals Inc

1
AMEX:ARMP (USA)  
$ 2.62 +0.02 (+0.77%) 10:08 PM EST
At Loss
Market Cap:
$ 94.72M
Enterprise V:
$ 224.77M
Volume:
5.31K
Avg Vol (2M):
16.17K
Also Trade In:
Volume:
5.31K
At Loss
Avg Vol (2M):
16.17K

Business Description

Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Name Current Vs Industry Vs History
Cash-To-Debt 0.23
Equity-to-Asset -0.47
Debt-to-Equity -2.97
Debt-to-EBITDA -2.1
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -13.4
3-Year EPS without NRI Growth Rate -10.1
3-Year FCF Growth Rate -9.8
Name Current Vs Industry Vs History
5-Day RSI 45.9
9-Day RSI 45.07
14-Day RSI 44.55
6-1 Month Momentum % 23.15
12-1 Month Momentum % 82.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.38
Cash Ratio 0.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.6
Shareholder Yield % -70.12

Financials (Next Earnings Date:2024-08-14 Est.)

ARMP's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:ARMP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Armata Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.27
Beta 1.33
Volatility % 147.07
14-Day RSI 44.55
14-Day ATR ($) 0.342148
20-Day SMA ($) 2.69406
12-1 Month Momentum % 82.48
52-Week Range ($) 1.0701 - 5.2565
Shares Outstanding (Mil) 36.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Armata Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Armata Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Armata Pharmaceuticals Inc Frequently Asked Questions

What is Armata Pharmaceuticals Inc(ARMP)'s stock price today?
The current price of ARMP is $2.62. The 52 week high of ARMP is $5.26 and 52 week low is $1.07.
When is next earnings date of Armata Pharmaceuticals Inc(ARMP)?
The next earnings date of Armata Pharmaceuticals Inc(ARMP) is 2024-08-14 Est..
Does Armata Pharmaceuticals Inc(ARMP) pay dividends? If so, how much?
Armata Pharmaceuticals Inc(ARMP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1